ACTONEL cpr 35 mg gastro-résistantes 4 pce

7680691440014 CH-69144 M05BA07 07.99.0.

Reimbursement limitations:

ACTONEL.01

Pour le traitement de l'ostéoporose documentée.

ACTONEL cpr 35 mg gastro-résistantes 4 pce
ACTONEL cpr 35 mg gastro-résistantes 4 pce
ACTONEL cpr 35 mg gastro-résistantes 4 pce
1 / 3
google

Details

Product number
6914401
CPT
-
Packaging group
4
Unit
Tablette(n)
Composition
natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum A, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, E 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg.

Articles (1)

Actonel 35 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2024
Patient information leaflet
Français
29/07/2024
Patient information leaflet
Italien
29/07/2024
Professional SmPC
Allemand
29/07/2024
Professional SmPC
Français
29/07/2024
Professional SmPC
Italien
29/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
35.0 MG Substance WIZUS
(N/A)
32.48 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
16.64 MG Substance HBESI

Reimbursement information

Public price
CHF 33.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2024

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
69144
Drug name
Actonel, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
M05BA07
Authorization status
Z
Dispensation category
B
First authorization
14/02/2024
Authorization expiration date
13/02/2029
IT number
07.99.0.
Domain
Human medicine
Field of application
Behandlung der Osteoporose bei postmenopausalen Frauen mit erhöhtem Frakturrisiko

Packaging details

Description (FR)
ACTONEL cpr 35 mg gastro-résistantes 4 pce
Description (DE)
ACTONEL Tabl 35 mg magensaftresistent 4 Stk
Market launch
14/02/2024
Narcotic (BTM)
No

Other packaging sizes

ACTONEL cpr 35 mg gastro-résistantes 12 pce
12 TABL
View